Neumora Therapeutics (NMRA) EPS (Basic) (2022 - 2026)
Neumora Therapeutics (NMRA) posted quarterly EPS (Basic) of -$0.3 for Q1 2026, up 29.43% year-over-year from -$0.23 in Q1 2025, and up 18.25% quarter-over-quarter from -$0.36 in Q4 2025.
Powered by 
Analysis
Neumora Therapeutics (NMRA) EPS (Basic) (2022 - 2026) Analysis & Trends
Neumora Therapeutics' EPS (Basic) history runs 5 years deep, the most recent figure standing at -$0.3 for Q1 2026.
- In Q1 2026, EPS (Basic) rose 29.43% year-over-year to -$0.3; the TTM figure through Mar 2026 stood at -$1.24 (up 22.66% YoY), while the FY2025 annual figure was -$1.45, up 5.22% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.3, up from -$0.36 in the prior quarter.
- The five-year high for EPS (Basic) was -$0.3 in Q1 2026, with the low at -$6.32 in Q4 2022.
- The 5-year median for EPS (Basic) is -$0.42 (2025), against an average of -$1.08.
- The sharpest annual moves came in 2024 and 2025: EPS (Basic) jumped 77.88% in 2024, then dropped 23.82% in 2025.
- Neumora Therapeutics' EPS (Basic) stood at -$6.32 in 2022, then surged by 73.6% to -$1.67 in 2023, then soared by 77.88% to -$0.37 in 2024, then gained by 1.47% to -$0.36 in 2025, then gained by 18.25% to -$0.3 in 2026.
- Business Quant data shows NMRA's EPS (Basic) at -$0.3 in Q1 2026, -$0.36 in Q4 2025, and -$0.35 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.76 Bn | 131.91 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.72 Bn | 77.72 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.56 Bn | 58.38 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 57.87 Bn | 52.73 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.06 Bn | 44.06 Bn | - | -3.06 |
| 6 | BeOne Medicines | 40.08 Bn | 34.98 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.50 Bn | 32.20 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.54 Bn | 27.70 Bn | - | 0.18 |
| 9 | Insmed | 27.49 Bn | 26.33 Bn | 358.27 Mn | -0.06 |
| 10 | Neumora Therapeutics | 243.49 Mn | 243.49 Mn | - | -0.23 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.23 |
| Mar 31, 2026 | -0.30 |
| Dec 31, 2025 | -0.06 |
| Sep 30, 2025 | -0.35 |
| Jun 30, 2025 | -0.33 |
| Mar 31, 2025 | -0.42 |
| Dec 31, 2024 | -0.37 |
| Sep 30, 2024 | -0.45 |
| Jun 30, 2024 | -0.37 |
| Mar 31, 2024 | -0.34 |
| Dec 31, 2023 | -1.67 |
| Sep 30, 2023 | -1.14 |
| Jun 30, 2023 | -1.28 |
| Mar 31, 2023 | -1.32 |
| Dec 31, 2022 | -1.05 |
| Sep 30, 2022 | -1.06 |